Nanoparticle SARS-CoV-2 model offers faster route for COVID-19 drug discovery
Researchers from the National Center for Advancing Translations Sciences (NCATS; MD, USA) and Naval Research Laboratory (NRL; DC, USA) have modelled the novel coronavirus SARS-CoV-2 using a fluorescent nanoparticle probe. The tool mimics how the virus infects a cell, which could help scientists in the search for treatments for COVID-19. The findings, which were published in ACS Nano, showed that the probe could be used to quickly determine the ability of biologics, drugs and compounds to block the infiltration of the novel coronavirus. Kirill Gorshkov (NCATS), first author of the study, explained: "Our goal is to create a screening system...
To view this content, please register now for access
Join our member community for FREE to access a collection of journal and online-only features, including:
- Exclusive access to educational videos, eBooks and insights into top BioTechniques journal articles
- The latest news and journal updates delivered straight to your inbox when you want it
- Personalized recommendations for the latest member-exclusive podcasts, interviews and expert opinions
- Priority registration to webinars, panel discussions and events
- Access to competitions and journal publication discounts, including 10% off open access fees when you sign up today!